GOLDMAN SACHS GROUP INC - AVID BIOSERVICES INC ownership

AVID BIOSERVICES INC's ticker is CDMO and the CUSIP is 05368M106. A total of 189 filers reported holding AVID BIOSERVICES INC in Q2 2022. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AVID BIOSERVICES INC
ValueSharesWeighting
Q3 2023$2,737,846
-48.2%
290,026
-23.3%
0.00%0.0%
Q2 2023$5,285,843
-32.1%
378,371
-8.8%
0.00%
-50.0%
Q1 2023$7,785,062
+25.7%
414,982
-7.7%
0.00%
+100.0%
Q4 2022$6,193,788
-17.8%
449,803
+14.2%
0.00%
-50.0%
Q3 2022$7,533,000
+41.1%
394,005
+12.6%
0.00%
+100.0%
Q2 2022$5,340,000
-36.9%
349,936
-15.8%
0.00%
-50.0%
Q1 2022$8,469,000
-45.4%
415,735
-21.8%
0.00%
-33.3%
Q4 2021$15,517,000
-10.1%
531,776
-33.5%
0.00%
-25.0%
Q3 2021$17,252,000
-49.9%
799,827
-40.4%
0.00%
-50.0%
Q2 2021$34,403,000
+135.9%
1,341,277
+67.7%
0.01%
+100.0%
Q1 2021$14,584,000
+213.9%
800,030
+98.7%
0.00%
+300.0%
Q4 2020$4,646,000
+318.2%
402,546
+176.2%
0.00%
Q3 2020$1,111,000
+37.3%
145,764
+18.2%
0.00%
Q2 2020$809,000
+50.4%
123,274
+17.1%
0.00%
Q1 2020$538,000
-60.9%
105,294
-41.3%
0.00%
Q4 2019$1,376,000
-35.7%
179,448
-55.6%
0.00%
-100.0%
Q3 2019$2,141,000
+1900.9%
403,799
+2006.0%
0.00%
Q2 2019$107,000
-27.2%
19,174
-44.6%
0.00%
Q1 2019$147,000
-56.8%
34,595
-58.3%
0.00%
Q4 2018$340,000
-0.6%
82,927
+66.2%
0.00%
Q3 2018$342,000
+64.4%
49,902
-29.9%
0.00%
Q1 2018$208,00071,1690.00%
Other shareholders
AVID BIOSERVICES INC shareholders Q2 2022
NameSharesValueWeighting ↓
AltraVue Capital, LLC 3,009,189$28,406,7443.38%
Sargent Investment Group, LLC 720,961$6,805,8721.64%
Ranger Investment Management 2,281,112$21,533,6971.43%
AWM Investment Company, Inc. 999,926$9,439,3011.39%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 1,186,639$11,201,8710.72%
Roubaix Capital, LLC 77,843$734,8380.54%
SNYDER CAPITAL MANAGEMENT L P 2,230,931$21,059,9890.48%
GENEVA CAPITAL MANAGEMENT LLC 2,258,671$21,321,8570.45%
272 Capital LP 110,702$1,045,0270.42%
PALISADE CAPITAL MANAGEMENT, LP 1,572,840$14,847,6100.41%
View complete list of AVID BIOSERVICES INC shareholders